{"content":"<li class=\"n-box-item date-title\" data-end=\"1341287999\" data-start=\"1341201600\" data-txt=\"Wednesday, December 18, 2019\">Monday, July  2, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"397381\" data-ts=\"1341266065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/397381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Resources (NASDAQ:ROSE) +4.1% AH as Standard &amp;amp;&amp;nbsp;Poor&#39;s says the oil and gas...</a></h4><p>Rosetta Resources (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ROSE\" title=\"Rosehill Resources Inc.\">ROSE</a>) <font color=\"green\">+4.1%</font> AH as Standard &amp; Poor's says the oil and gas exploration and production company <a target=\"_blank\" href=\"http://www.standardandpoors.com/servlet/BlobServer?blobheadername3=MDT-Type&amp;blobcol=urldocumentfile&amp;blobtable=SPComSecureDocument&amp;blobheadervalue2=inline%3B+filename%3Ddownload.pdf&amp;blobheadername2=Content-Disposition&amp;blobheadervalue1=application%2Fpdf&amp;blobkey=id&amp;blobheadername1=content-type&amp;blobwhere=1245336219236&amp;blobheadervalue3=abinary%3B+charset%3DUTF-8&amp;blobnocache=true\">will replace</a> Catalyst Health Solutions (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CHSI\" title=\"Catalyst Health Solutions, Inc\">CHSI</a>) in the S&amp;P MidCap 400 Index after the close of trading July 5. </p><div class=\"tiny-share-widget\" data-id=\"397381\" data-linked=\"Rosetta Resources (NASDAQ:ROSE) +4.1% AH as Standard &amp;amp; Poor&#39;s says the oil and gas...\" data-tweet=\"$NBL $NBL $CHSI - Rosetta Resources (NASDAQ:ROSE) +4.1% AH as Standard &amp; Poor&#39;s says the oil and gas exploration and production company will replace Catalyst Health Solutions (NASDAQ:CHSI) in the S&amp;P MidCap 400 Index after the close of trading July 5. https://seekingalpha.com/news/397381?source=tweet\" data-url=\"https://seekingalpha.com/news/397381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"397291\" data-ts=\"1341263335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIRE\" target=\"_blank\">FIRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/397291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sourcefire (NASDAQ:FIRE) -3.2% AH after announcing CEO John Burris is taking a leave of absence...</a></h4><p>Sourcefire (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FIRE\" title=\"Sourcefire, Inc.\">FIRE</a>) <font color=\"red\">-3.2%</font> AH after announcing CEO John Burris is taking a leave of absence to undergo treatment for colon cancer.  Founder and CTO Martin Roesch has been named interim CEO. In addition, Sourcefire says it expects Q2 revenue and EPS to be at the high end of its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/283881\">guidance ranges</a>, or slightly above. (PR) </p><div class=\"tiny-share-widget\" data-id=\"397291\" data-linked=\"Sourcefire (NASDAQ:FIRE) -3.2% AH after announcing CEO John Burris is taking a leave of absence...\" data-tweet=\"$FIRE - Sourcefire (NASDAQ:FIRE) -3.2% AH after announcing CEO John Burris is taking a leave of absence to undergo treatment for colon cancer.  Founder and CTO Martin Roesch has been named interim CEO. In addition, Sourcefire says it expects Q2 revenue ... https://seekingalpha.com/news/397291?source=tweet\" data-url=\"https://seekingalpha.com/news/397291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"397201\" data-ts=\"1341261264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/397201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon (GRPN -10.5%) chairman and co-founder Eric Lefkofsky discloses on his blog he will be...</a></h4> Groupon (<a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color=\"red\">-10.5%</font>) chairman and co-founder Eric Lefkofsky <a target=\"_blank\" href=\"http://www.lefkofsky.com/blog/a-nice-ring-to-it\" target=\"_blank\">discloses</a> on his blog he will be assuming a reduced role at the daily deals giant, and will spend more time working with VC firm Lightbank. That, in addition to <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/396061\" target=\"_blank\">Susquehanna's note</a>, likely contributed to Groupon's selloff today, particularly given the Street's lingering concerns about CEO <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/88946\" target=\"_blank\">Andrew Mason</a>. <div class=\"tiny-share-widget\" data-id=\"397201\" data-linked=\"Groupon (GRPN -10.5%) chairman and co-founder Eric Lefkofsky discloses on his blog he will be...\" data-tweet=\"$GRPN - Groupon (GRPN -10.5%) chairman and co-founder Eric Lefkofsky discloses on his blog he will be assuming a reduced role at the daily deals giant, and will spend more time working with VC firm Lightbank. That, in addition to Susquehanna&#39;s note, lik... https://seekingalpha.com/news/397201?source=tweet\" data-url=\"https://seekingalpha.com/news/397201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"397031\" data-ts=\"1341257016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QGEN\" target=\"_blank\">QGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/397031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qiagen (QGEN +1.7%) trades up after Goldman upgraded the shares to Neutral today, based on...</a></h4><p>Qiagen (<a href=\"https://seekingalpha.com/symbol/QGEN\" title=\"Qiagen N.V.\">QGEN</a> <font color=\"green\">+1.7%</font>) trades up after Goldman <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Qiagen+NV+%28QGEN%29+to+Neutral/7552537.html\">upgraded the shares</a> to Neutral today, based on reduced risk to 2012 estimates and an M&amp;A premium due to the scarcity value of its assets. </p><div class=\"tiny-share-widget\" data-id=\"397031\" data-linked=\"Qiagen (QGEN +1.7%) trades up after Goldman upgraded the shares to Neutral today, based on...\" data-tweet=\"$QGEN - Qiagen (QGEN +1.7%) trades up after Goldman upgraded the shares to Neutral today, based on reduced risk to 2012 estimates and an M&amp;A premium due to the scarcity value of its assets. https://seekingalpha.com/news/397031?source=tweet\" data-url=\"https://seekingalpha.com/news/397031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"397001\" data-ts=\"1341256764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/397001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janney Capital Markets sees retailers reporting June sales slightly below consensus on its...</a></h4><p>Janney Capital Markets sees retailers reporting June sales slightly below consensus on its outlook that a pickup in promotions will <a target=\"_blank\" href=\"http://online.barrons.com/article/SB50001424053111903431804577502773674910792.html?ru=yahoo&amp;mod=yahoobarrons\">cut into</a> the impact of volume increases. Channel checks by the firm indicate American Eagle Outfitters (<a href=\"https://seekingalpha.com/symbol/AEO\" title=\"American Eagle Outfitters, Inc.\">AEO</a> <font color=\"green\">+0.6%</font>) and Pacific Sunwear (<a href=\"https://seekingalpha.com/symbol/PSUN\" title=\"Pacific Sunwear of California, Inc.\">PSUN</a> <font color=\"red\">-0.5%</font>) are two names that are trending to the less promotional side, while Abercrombie &amp; Fitch (<a href=\"https://seekingalpha.com/symbol/ANF\" title=\"Abercrombie &amp; Fitch\">ANF</a> <font color=\"red\">-0.9%</font>) and Bebe Stores (<a href=\"https://seekingalpha.com/symbol/BEBE\" title=\"bebe stores, inc.\">OTC:BEBE</a> <font color=\"green\">+0.3%</font>) could deliver results below expectations due to their heavy promotional activity.</p><div class=\"tiny-share-widget\" data-id=\"397001\" data-linked=\"Janney Capital Markets sees retailers reporting June sales slightly below consensus on its...\" data-tweet=\"$AEO $AEO $PSUN - Janney Capital Markets sees retailers reporting June sales slightly below consensus on its outlook that a pickup in promotions will cut into the impact of volume increases. Channel checks by the firm indicate American Eagle Outfitters ... https://seekingalpha.com/news/397001?source=tweet\" data-url=\"https://seekingalpha.com/news/397001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396951\" data-ts=\"1341255336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSX\" target=\"_blank\">PSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phillips 66 (PSX +2.4%) jumps after Deutsche Bank upgrades the refiner to Buy from Hold as &quot;the...</a></h4><p>Phillips 66 (<a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a> <font color=\"green\">+2.4%</font>) jumps after Deutsche Bank <a target=\"_blank\" href=\"http://www.marketwatch.com/story/phillips-66-rises-on-deutsche-bank-upgrade-2012-07-02\">upgrades</a> the refiner to Buy from Hold as \"the premium  unconventional oil play.\" The top beneficiary of the \"secular long-term boom\" in U.S. oil and  gas production will be export-oriented processing manufacturers, with refining the \"biggest, most undervalued sector,\" the firm says. It also lists <a href=\"https://seekingalpha.com/symbol/HFC\" title=\"HollyFrontier Corp.\">HFC</a> as a Top Pick and upgrades <a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> to Buy. </p><div class=\"tiny-share-widget\" data-id=\"396951\" data-linked=\"Phillips 66 (PSX +2.4%) jumps after Deutsche Bank upgrades the refiner to Buy from Hold as &quot;the...\" data-tweet=\"$PSX $PSX $HFC - Phillips 66 (PSX +2.4%) jumps after Deutsche Bank upgrades the refiner to Buy from Hold as &quot;the premium unconventional oil play.&quot; The top beneficiary of the &quot;secular long-term boom&quot; in U.S. oil and gas production will be export-oriented... https://seekingalpha.com/news/396951?source=tweet\" data-url=\"https://seekingalpha.com/news/396951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396941\" data-ts=\"1341255078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QIHU\" target=\"_blank\">QIHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qihoo 360 (QIHU -5.4%) dives after hacker group Anonymous becomes the latest to issue a report...</a></h4> Qihoo 360 (<a href='https://seekingalpha.com/symbol/QIHU' title='QIHOO 360 Technology Co. Ltd.'>QIHU</a> <font color=\"red\">-5.4%</font>) dives after hacker group Anonymous becomes the latest to <a target=\"_blank\" href=\"http://www.techinasia.com/anonymous-analytics-report-qihoo/\">issue a report</a> questioning the company's traffic data for its hao.360.cn portal. Anonymous claims Qihoo recently removed code that was installed several months ago so that comScore could measure its traffic, and did so without ever publishing comScore's results. <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/98873\">Citron Research</a> and SA's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/377951\">Richard N. Davis</a> have already questioned Qihoo's traffic stats. <div class=\"tiny-share-widget\" data-id=\"396941\" data-linked=\"Qihoo 360 (QIHU -5.4%) dives after hacker group Anonymous becomes the latest to issue a report...\" data-tweet=\"$QIHU - Qihoo 360 (QIHU -5.4%) dives after hacker group Anonymous becomes the latest to issue a report questioning the company&#39;s traffic data for its hao.360.cn portal. Anonymous claims Qihoo recently removed code that was installed several months ago s... https://seekingalpha.com/news/396941?source=tweet\" data-url=\"https://seekingalpha.com/news/396941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396921\" data-ts=\"1341254689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMPE\" target=\"_blank\">AMPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396921\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The expiration of stock-sale lockups for Ampio Pharmaceuticals&#39; (AMPE +7%) executives and...</a></h4><p>The expiration of <a target=\"_blank\" href=\"http://www.thestreet.com/story/11604273/1/ampio-insiders-aided-by-pr-blitz-soon-free-to-sell-millions-of-shares.html\">stock-sale lockups</a> for Ampio Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/AMPE\" title=\"Ampio Pharmaceuticals, Inc.\">AMPE</a> <font color=\"green\">+7%</font>) executives and insiders - due at the end of June and in mid-July - just happens to coincide with the stock's recent run up. The Street's Adam Feuerstein is calling shenanigans on the company, accusing the company of fueling a promotional blitz in an effort to pump up the price for the benefit of insiders. </p><div class=\"tiny-share-widget\" data-id=\"396921\" data-linked=\"The expiration of stock-sale lockups for Ampio Pharmaceuticals&#39; (AMPE +7%) executives and...\" data-tweet=\"$AMPE - The expiration of stock-sale lockups for Ampio Pharmaceuticals&#39; (AMPE +7%) executives and insiders - due at the end of June and in mid-July - just happens to coincide with the stock&#39;s recent run up. The Street&#39;s Adam Feuerstein is calling shenan... https://seekingalpha.com/news/396921?source=tweet\" data-url=\"https://seekingalpha.com/news/396921\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396901\" data-ts=\"1341254494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUN\" target=\"_blank\">HUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In addition to downgrading DuPont, Jefferies reduces its earnings estimates for chemical maker...</a></h4><p>In addition to <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/396011\">downgrading</a> DuPont, Jefferies <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Jefferies+Reiterates+a+Hold+on+Huntsman+%28HUN%29%3B+Cutting+Estimates+and+PT+as+Outlook+More+Tempered/7553057.html\">reduces its earnings estimates</a> for chemical maker Huntsman (<a href=\"https://seekingalpha.com/symbol/HUN\" title=\"Huntsman Corporation\">HUN</a> <font color=\"red\">-3.7%</font>) due to expectations for rising costs among pigments and sinking demand for HUN's products in Europe and Asia. The firm leaves its Hold rating unchanged but cuts its target price to $14.50 from $16. </p><div class=\"tiny-share-widget\" data-id=\"396901\" data-linked=\"In addition to downgrading DuPont, Jefferies reduces its earnings estimates for chemical maker...\" data-tweet=\"$HUN - In addition to downgrading DuPont, Jefferies reduces its earnings estimates for chemical maker Huntsman (HUN -3.7%) due to expectations for rising costs among pigments and sinking demand for HUN&#39;s products in Europe and Asia. The firm leaves its ... https://seekingalpha.com/news/396901?source=tweet\" data-url=\"https://seekingalpha.com/news/396901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396891\" data-ts=\"1341254327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMRN\" target=\"_blank\">BMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray looks at other potential takeout candidates in the biotech space post-Amylin,...</a></h4> Piper Jaffray looks at other <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?location=recommendations.php\">potential takeout candidates</a> in the biotech space post-Amylin, highlighting BioMarin (<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color=\"green\">+3.8%</font>), Affymax (<a href='https://seekingalpha.com/symbol/AFFY' title='Affymax, Inc.'>OTC:AFFY</a> <font color=\"green\">+1%</font>), Theravance (THRX <font color=\"green\">+8.3%</font>), and Rigel Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a> <font color=\"green\">+2.3%</font>) all as potential candidates. Piper notes that BioMarin could fetch as much as $79 per share, and notes that Japanese drug heavyweight Takeda Pharmaceuticals (TKPYY.PK) could be the most likely suitor for Affymax. <div class=\"tiny-share-widget\" data-id=\"396891\" data-linked=\"Piper Jaffray looks at other potential takeout candidates in the biotech space post-Amylin,...\" data-tweet=\"$BMRN $BMRN $AFFY - Piper Jaffray looks at other potential takeout candidates in the biotech space post-Amylin, highlighting BioMarin (BMRN +3.8%), Affymax (OTC:AFFY +1%), Theravance (THRX +8.3%), and Rigel Pharmaceuticals (RIGL +2.3%) all as potential ... https://seekingalpha.com/news/396891?source=tweet\" data-url=\"https://seekingalpha.com/news/396891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396851\" data-ts=\"1341253381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDOT\" target=\"_blank\">GDOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Dot (GDOT +9.4%) soars on heavy volume after Jefferies tips off that Wal-Mart pulled...</a></h4><p>Green Dot (<a href=\"https://seekingalpha.com/symbol/GDOT\" title=\"Green Dot Corporation\">GDOT</a> <font color=\"green\">+9.4%</font>) soars on heavy volume after Jefferies tips off that Wal-Mart <a target=\"_blank\" href=\"http://in.reuters.com/article/2012/07/02/us-greendot-shares-idINBRE86111920120702\">pulled</a> American Express Bluebird cards as a form of payment from many of its stores. The company has been under increasing scrutiny in 2012 with bigger players such as JPMorgan and American Express shouldering into the prepaid car market.</p><div class=\"tiny-share-widget\" data-id=\"396851\" data-linked=\"Green Dot (GDOT +9.4%) soars on heavy volume after Jefferies tips off that Wal-Mart pulled...\" data-tweet=\"$GDOT - Green Dot (GDOT +9.4%) soars on heavy volume after Jefferies tips off that Wal-Mart pulled American Express Bluebird cards as a form of payment from many of its stores. The company has been under increasing scrutiny in 2012 with bigger players s... https://seekingalpha.com/news/396851?source=tweet\" data-url=\"https://seekingalpha.com/news/396851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396831\" data-ts=\"1341253067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The GAO has upheld the $20.5B contract awarded to UnitedHealth Group ([[UNH] -2.2%) by the DoD,...</a></h4><p>The GAO has upheld the $20.5B <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-07-02/unitedhealth-s-20-5-billion-pentagon-award-upheld-by-agency-1-.html\">contract awarded</a> to UnitedHealth Group ([[UNH] <font color=\"red\">-2.2%</font>) by the DoD, saying it was \"reasonable,\" and rejected TriWest Healthcare Alliance's request for reconsideration. TriWest had protested the decision with the GAO, which arbitrates contract disputes, saying DoD officials had told them during a post-award briefing that their company had actually made a lower bid for the work. </p><div class=\"tiny-share-widget\" data-id=\"396831\" data-linked=\"The GAO has upheld the $20.5B contract awarded to UnitedHealth Group ([[UNH] -2.2%) by the DoD,...\" data-tweet=\"The GAO has upheld the $20.5B contract awarded to UnitedHealth Group ([[UNH] -2.2%) by the DoD, saying it was &quot;reasonable,&quot; and rejected TriWest Healthcare Alliance&#39;s request for reconsideration. TriWest had protested the decision with the GAO, which ar... https://seekingalpha.com/news/396831?source=tweet\" data-url=\"https://seekingalpha.com/news/396831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396821\" data-ts=\"1341252383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Now that Amylin (AMLN) is being sold, Rodman &amp;amp; Renshaw&#39;s Michael King says fellow diabetes...</a></h4> Now that Amylin (<a href='https://seekingalpha.com/symbol/AMLN' title=''>AMLN</a>) is <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394871\">being sold</a>, Rodman &amp; Renshaw's Michael King says fellow diabetes firms MannKind (<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color=\"green\">+6.55%</font>) and Vivus (<a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color=\"green\">+0.4%</font>) could be acquisition targets as well. It's worth noting, though, that King's speculation accompanies a <a target=\"_blank\" href=\"http://blogs.wsj.com/deals/2012/07/02/analyst-admits-bad-call-on-amylin-but-has-new-ideas\">mea culpa</a> for being wrong about Amylin, whose assets he described as \"mediocre.\" <div class=\"tiny-share-widget\" data-id=\"396821\" data-linked=\"Now that Amylin (AMLN) is being sold, Rodman &amp;amp; Renshaw&#39;s Michael King says fellow diabetes...\" data-tweet=\"$BMY $BMY $MNKD - Now that Amylin (AMLN) is being sold, Rodman &amp; Renshaw&#39;s Michael King says fellow diabetes firms MannKind (MNKD +6.55%) and Vivus (VVUS +0.4%) could be acquisition targets as well. It&#39;s worth noting, though, that King&#39;s speculation acc... https://seekingalpha.com/news/396821?source=tweet\" data-url=\"https://seekingalpha.com/news/396821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396781\" data-ts=\"1341251630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFFX\" target=\"_blank\">AFFX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396781\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Affymetrix (AFFX -3%) slips after Goldman cut the shares to Sell on valuation, citing concerns...</a></h4> Affymetrix (<a href='https://seekingalpha.com/symbol/AFFX' title='Affymetrix, Inc.'>AFFX</a> <font color=\"red\">-3%</font>) slips after Goldman <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Affymetrix+%28AFFX%29+to+Sell/7552553.html\">cut the shares</a> to Sell on valuation, citing concerns that eBio won't be sufficient to stave off end market headwinds. <div class=\"tiny-share-widget\" data-id=\"396781\" data-linked=\"Affymetrix (AFFX -3%) slips after Goldman cut the shares to Sell on valuation, citing concerns...\" data-tweet=\"$AFFX - Affymetrix (AFFX -3%) slips after Goldman cut the shares to Sell on valuation, citing concerns that eBio won&#39;t be sufficient to stave off end market headwinds. https://seekingalpha.com/news/396781?source=tweet\" data-url=\"https://seekingalpha.com/news/396781\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396771\" data-ts=\"1341251510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCYC\" target=\"_blank\">PCYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pharmacyclics (PCYC +5.7%) continues where it left off in June, when it surged 74% on the...</a></h4><p>Pharmacyclics (<a href=\"https://seekingalpha.com/symbol/PCYC\" title=\"Pharmacyclics, Inc.\">PCYC</a> <font color=\"green\">+5.7%</font>) continues where it <a target=\"_blank\" href=\"http://www.forbes.com/sites/matthewherper/2012/06/30/pharmacyclics-outperformed-other-biotechs-in-june-with-a-74-gain/\">left off</a> in June, when it surged 74% on the prospects for its ibrutinib treatment for chronic lymphocytic leukemia. The stock has quintupled over the past year. Last month was generally a good one for biotechs, with seven gaining over 40%. </p><div class=\"tiny-share-widget\" data-id=\"396771\" data-linked=\"Pharmacyclics (PCYC +5.7%) continues where it left off in June, when it surged 74% on the...\" data-tweet=\"$PCYC - Pharmacyclics (PCYC +5.7%) continues where it left off in June, when it surged 74% on the prospects for its ibrutinib treatment for chronic lymphocytic leukemia. The stock has quintupled over the past year. Last month was generally a good one fo... https://seekingalpha.com/news/396771?source=tweet\" data-url=\"https://seekingalpha.com/news/396771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396751\" data-ts=\"1341251015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Best Buy (BBY +8.1%) keep trading higher even after a report from Reuters dismisses...</a></h4><p>Shares of Best Buy (<a href=\"https://seekingalpha.com/symbol/BBY\" title=\"Best Buy Co.\">BBY</a> <font color=\"green\">+8.1%</font>) keep trading higher even after a <a target=\"_blank\" href=\"http://www.chicagotribune.com/business/sns-rt-us-bestbuy-lbobre86110v-20120702,0,1550961.story\">report</a> from Reuters dismisses with an air of confidence the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/396091\">earlier chatter</a> that Richard Schulze is close to pitching the Best Buy board on a buyout plan. With shares of BBY up close to 30% from their monthly lows, <a target=\"_blank\" href=\"https://twitter.com/LaMonicaBuzz/status/219838840855216128\">more skeptics</a> are coming out of the woodwork with the take that even if a leveraged buyout offer flies, the premium may be slim to none.</p><div class=\"tiny-share-widget\" data-id=\"396751\" data-linked=\"Shares of Best Buy (BBY +8.1%) keep trading higher even after a report from Reuters dismisses...\" data-tweet=\"$BBY - Shares of Best Buy (BBY +8.1%) keep trading higher even after a report from Reuters dismisses with an air of confidence the earlier chatter that Richard Schulze is close to pitching the Best Buy board on a buyout plan. With shares of BBY up close... https://seekingalpha.com/news/396751?source=tweet\" data-url=\"https://seekingalpha.com/news/396751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396711\" data-ts=\"1341250262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar Tree (DLTR -4.5%) doesn&#39;t participate in the mild rally of the stocks of discounters...</a></h4>Dollar Tree (<a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a> <font color=\"red\">-4.5%</font>) doesn't participate in the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/396231\">mild rally</a> of the stocks of discounters after Deutsche Bank <a target=\"_blank\" href=\"https://twitter.com/Briefingcom/status/219830313633845250\">cuts</a> its rating to Hold from Buy due to valuation after shares ran up 23% YTD. <div class=\"tiny-share-widget\" data-id=\"396711\" data-linked=\"Dollar Tree (DLTR -4.5%) doesn&#39;t participate in the mild rally of the stocks of discounters...\" data-tweet=\"$DLTR - Dollar Tree (DLTR -4.5%) doesn&#39;t participate in the mild rally of the stocks of discounters after Deutsche Bank cuts its rating to Hold from Buy due to valuation after shares ran up 23% YTD. https://seekingalpha.com/news/396711?source=tweet\" data-url=\"https://seekingalpha.com/news/396711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396661\" data-ts=\"1341248896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMO\" target=\"_blank\">TMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Life Technologies (LIFE -3.2%) slips after Goldman downgraded shares to Sell from Neutral on...</a></h4> Life Technologies (<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color=\"red\">-3.2%</font>) slips after Goldman <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Life+Technologies+%28LIFE%29+to+Sell%3B+Value+Trap/7552557.html\">downgraded shares</a> to Sell from Neutral on valuation this morning. The firm calls the stock a value trap, noting a combination of cyclical and structural challenges are creating growth headwinds for the company that will likely lead to disappointing operating results in H212 and possible beyond. <div class=\"tiny-share-widget\" data-id=\"396661\" data-linked=\"Life Technologies (LIFE -3.2%) slips after Goldman downgraded shares to Sell from Neutral on...\" data-tweet=\"$TMO - Life Technologies (LIFE -3.2%) slips after Goldman downgraded shares to Sell from Neutral on valuation this morning. The firm calls the stock a value trap, noting a combination of cyclical and structural challenges are creating growth headwinds f... https://seekingalpha.com/news/396661?source=tweet\" data-url=\"https://seekingalpha.com/news/396661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396621\" data-ts=\"1341248220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena Pharmaceuticals (ARNA -3.6%) continues to give back some of the massive gains it enjoyed...</a></h4><p>Arena Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ARNA\" title=\"Arena Pharmaceuticals, Inc.\">ARNA</a> <font color=\"red\">-3.6%</font>) continues to give back some of the massive gains it enjoyed after the FDA <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/389301\">approved</a> its weight-loss drug Belviq. Orexigen, which <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/391751\">surged</a> on the news as well, is <font color=\"red\">-4.7%</font>. Vivus, though, (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+1.5%</font>) is still climbing ahead of an FDA <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/389331\">decision</a> on its Qnexa diet drug on July 17. </p><div class=\"tiny-share-widget\" data-id=\"396621\" data-linked=\"Arena Pharmaceuticals (ARNA -3.6%) continues to give back some of the massive gains it enjoyed...\" data-tweet=\"$ARNA $ARNA $VVUS - Arena Pharmaceuticals (ARNA -3.6%) continues to give back some of the massive gains it enjoyed after the FDA approved its weight-loss drug Belviq. Orexigen, which surged on the news as well, is -4.7%. Vivus, though, (VVUS +1.5%) is s... https://seekingalpha.com/news/396621?source=tweet\" data-url=\"https://seekingalpha.com/news/396621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396611\" data-ts=\"1341247970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYGN\" target=\"_blank\">MYGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396611\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myriad Genetics (MYGN +3.3%) moves up this morning after Goldman upgraded shares to Buy with a...</a></h4><p>Myriad Genetics (<a href=\"https://seekingalpha.com/symbol/MYGN\" title=\"Myriad Genetics, Inc.\">MYGN</a> <font color=\"green\">+3.3%</font>) moves up this morning after Goldman <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Myriad+Genetics+%28MYGN%29+to+Buy/7552530.html\">upgraded shares</a> to Buy with a price target of $29. The firm says reimbursement concerns are overdone, plus the stock should gain added traction from the strength of its pipeline and a potential new dividend. </p><div class=\"tiny-share-widget\" data-id=\"396611\" data-linked=\"Myriad Genetics (MYGN +3.3%) moves up this morning after Goldman upgraded shares to Buy with a...\" data-tweet=\"$MYGN - Myriad Genetics (MYGN +3.3%) moves up this morning after Goldman upgraded shares to Buy with a price target of $29. The firm says reimbursement concerns are overdone, plus the stock should gain added traction from the strength of its pipeline an... https://seekingalpha.com/news/396611?source=tweet\" data-url=\"https://seekingalpha.com/news/396611\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396601\" data-ts=\"1341247836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPEN\" target=\"_blank\">OPEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Barclays&#39; downgrade of OpenTable (OPEN -11%): analyst Mark May estimates Q2 reservations...</a></h4> More on Barclays' <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/396081\">downgrade</a> of OpenTable (<a href='https://seekingalpha.com/symbol/OPEN' title='OpenTable, Inc.'>OPEN</a> <font color=\"red\">-11%</font>): analyst Mark May <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+EPS+Change/UPDATE%3A+Barclays+Downgrades+OpenTable+%28OPEN%29+to+Equalweight%3B+Stumbling+Into+Q2/7552515.html\">estimates</a> Q2 reservations and restaurant additions will come in at 30M and 622, respectively, below consensus estimates of 30.9M and 740. May expects these shortfalls, attributed to macro and restaurant industry trends, to result in a Q2 miss, but says he remains positive on OpenTable's long-term growth and competitive positioning. <div class=\"tiny-share-widget\" data-id=\"396601\" data-linked=\"More on Barclays&#39; downgrade of OpenTable (OPEN -11%): analyst Mark May estimates Q2 reservations...\" data-tweet=\"$OPEN - More on Barclays&#39; downgrade of OpenTable (OPEN -11%): analyst Mark May estimates Q2 reservations and restaurant additions will come in at 30M and 622, respectively, below consensus estimates of 30.9M and 740. May expects these shortfalls, attrib... https://seekingalpha.com/news/396601?source=tweet\" data-url=\"https://seekingalpha.com/news/396601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396531\" data-ts=\"1341246267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AROC\" target=\"_blank\">AROC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396531\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exterran (EXH +2.9%) says Williams Partners (NYSE:WPZ) awarded it a contract for the design,...</a></h4><p>Exterran (EXH <font color=\"green\">+2.9%</font>) says Williams Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/WPZ\" title=\"Williams Partners L.P.\">WPZ</a>) awarded it a contract for the design, fabrication and installation of natural gas facilities in West Virginia located in the natural gas liquid-rich portion of the Marcellus Shale. The project includes two cryogenic gas processing plants with refrigeration, each with a capacity of 200 mmcfe/day. </p><div class=\"tiny-share-widget\" data-id=\"396531\" data-linked=\"Exterran (EXH +2.9%) says Williams Partners (NYSE:WPZ) awarded it a contract for the design,...\" data-tweet=\"$AROC $AROC $WPZ - Exterran (EXH +2.9%) says Williams Partners (NYSE:WPZ) awarded it a contract for the design, fabrication and installation of natural gas facilities in West Virginia located in the natural gas liquid-rich portion of the Marcellus Shale... https://seekingalpha.com/news/396531?source=tweet\" data-url=\"https://seekingalpha.com/news/396531\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396521\" data-ts=\"1341246252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGEN\" target=\"_blank\">SGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396521\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seattle Genetics (SGEN +2.4%) bucks a downgrade to Underweight on valuation at Piper Jaffray...</a></h4><p>Seattle Genetics (<a href=\"https://seekingalpha.com/symbol/SGEN\" title=\"Seattle Genetics, Inc.\">SGEN</a> <font color=\"green\">+2.4%</font>) bucks a <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Piper+Jaffray+Downgrades+Seattle+Genetics+%28SGEN%29+to+Underweight/7552405.html\">downgrade to Underweight</a> on valuation at Piper Jaffray earlier today. Piper cut the shares on expectations for limited sales growth until further ADCETRIS data is released. The firm also lowers its price target to $20 from $22. </p><div class=\"tiny-share-widget\" data-id=\"396521\" data-linked=\"Seattle Genetics (SGEN +2.4%) bucks a downgrade to Underweight on valuation at Piper Jaffray...\" data-tweet=\"$SGEN - Seattle Genetics (SGEN +2.4%) bucks a downgrade to Underweight on valuation at Piper Jaffray earlier today. Piper cut the shares on expectations for limited sales growth until further ADCETRIS data is released. The firm also lowers its price tar... https://seekingalpha.com/news/396521?source=tweet\" data-url=\"https://seekingalpha.com/news/396521\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396491\" data-ts=\"1341245758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMCR\" target=\"_blank\">GMCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coffee names fall out of favor with investors as Green Mountain Coffee Roasters (GMCR -1.6%),...</a></h4><p>Coffee names fall out of favor with investors as Green Mountain Coffee Roasters (<a href=\"https://seekingalpha.com/symbol/GMCR\" title=\"Keurig Green Mountain Inc\">GMCR</a> <font color=\"red\">-1.6%</font>), Starbucks (<a href=\"https://seekingalpha.com/symbol/SBUX\" title=\"Starbucks Corporation\">SBUX</a> <font color=\"red\">-1.4%</font>), Peet's (<a href=\"https://seekingalpha.com/symbol/PEET\" title=\"Peet's Coffee &amp; Tea, Inc.\">PEET</a> <font color=\"red\">-2.9%</font>), and Coffee Holding (<a href=\"https://seekingalpha.com/symbol/JVA\" title=\"Coffee Holding Co., Inc\">JVA</a> <font color=\"red\">-1.5%</font>) all rack up losses for the day. It's the demand side of the supply and demand matrix that draws concern, with the <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424052702303561504577494772331679462.html\">conventional wisdom</a> that says consumers will pay premium prices for coffee through thick and thin starting to get turned on its head.</p><div class=\"tiny-share-widget\" data-id=\"396491\" data-linked=\"Coffee names fall out of favor with investors as Green Mountain Coffee Roasters (GMCR -1.6%),...\" data-tweet=\"$GMCR $GMCR $SBUX - Coffee names fall out of favor with investors as Green Mountain Coffee Roasters (GMCR -1.6%), Starbucks (SBUX -1.4%), Peet&#39;s (PEET -2.9%), and Coffee Holding (JVA -1.5%) all rack up losses for the day. It&#39;s the demand side of the sup... https://seekingalpha.com/news/396491?source=tweet\" data-url=\"https://seekingalpha.com/news/396491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396471\" data-ts=\"1341245414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVAN\" target=\"_blank\">IVAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ivanhoe Energy (IVAN +39%) shares surge after the company says it knows of no reason for the...</a></h4><p>Ivanhoe Energy (<a href=\"https://seekingalpha.com/symbol/IVAN\" title=\"Ivanhoe Energy, Inc.\">IVAN</a> <font color=\"green\">+39%</font>) shares surge after the company says it knows of no reason for the sudden decline in its stock price late in the June 29 trading session. The company says no material adverse developments have occurred to explain the drop, and top managers have maintained their  shareholdings and will increase them over time. </p><div class=\"tiny-share-widget\" data-id=\"396471\" data-linked=\"Ivanhoe Energy (IVAN +39%) shares surge after the company says it knows of no reason for the...\" data-tweet=\"$IVAN - Ivanhoe Energy (IVAN +39%) shares surge after the company says it knows of no reason for the sudden decline in its stock price late in the June 29 trading session. The company says no material adverse developments have occurred to explain the dr... https://seekingalpha.com/news/396471?source=tweet\" data-url=\"https://seekingalpha.com/news/396471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396461\" data-ts=\"1341245157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNEQ\" target=\"_blank\">SUNEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MEMC (WFR +19.6%), which had 12.3% of its float shorted as of June 15, skyrockets after...</a></h4><p>MEMC (WFR <font color=\"green\">+19.6%</font>), which had 12.3% of its float shorted as of June 15, skyrockets after announcing it executed contracts in Q2 for 4 European solar projects representing 98MW of installed capacity (60MW in Bulgaria, 38MW in Italy). The deals should help shore up MEMC's weak <a target=\"_blank\" href=\"http://finance.yahoo.com/q/bs?s=WFR\">balance sheet</a>. On Friday, MEMC announced the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394351\">sale</a> of a 20MW Nevada solar project. </p><div class=\"tiny-share-widget\" data-id=\"396461\" data-linked=\"MEMC (WFR +19.6%), which had 12.3% of its float shorted as of June 15, skyrockets after...\" data-tweet=\"$SUNEQ - MEMC (WFR +19.6%), which had 12.3% of its float shorted as of June 15, skyrockets after announcing it executed contracts in Q2 for 4 European solar projects representing 98MW of installed capacity (60MW in Bulgaria, 38MW in Italy). The deals sh... https://seekingalpha.com/news/396461?source=tweet\" data-url=\"https://seekingalpha.com/news/396461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396421\" data-ts=\"1341244297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FST\" target=\"_blank\">FST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forest Oil (FST -6.8%) is downgraded to Hold from Buy at Stifel Nicolaus, based on concern about...</a></h4><p>Forest Oil (<a href=\"https://seekingalpha.com/symbol/FST\" title=\"Forest Oil Corporation\">FST</a> <font color=\"red\">-6.8%</font>) is <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Stifel+Nicolaus+Downgrades+Forest+Oil+%28FST%29+to+Hold/7552586.html\">downgraded</a> to Hold from Buy at Stifel Nicolaus, based on concern about FST's ability to turn itself around. The firm sees downside to $5/share, citing high debt levels, meaningful cash flow outspend, downside risk to 2013 estimates and pricing exposure to natural gas liquids absent a sale of the company or a commodity price recovery. </p><div class=\"tiny-share-widget\" data-id=\"396421\" data-linked=\"Forest Oil (FST -6.8%) is downgraded to Hold from Buy at Stifel Nicolaus, based on concern about...\" data-tweet=\"$FST - Forest Oil (FST -6.8%) is downgraded to Hold from Buy at Stifel Nicolaus, based on concern about FST&#39;s ability to turn itself around. The firm sees downside to $5/share, citing high debt levels, meaningful cash flow outspend, downside risk to 201... https://seekingalpha.com/news/396421?source=tweet\" data-url=\"https://seekingalpha.com/news/396421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396391\" data-ts=\"1341244197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396391\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo BioSciences (SGMO -3.1%) takes a hit after being downgraded to Underweight from Neutral...</a></h4> Sangamo BioSciences (<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color=\"red\">-3.1%</font>) takes a hit after being <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Piper+Jaffray+Downgrades+Sangamo+BioSciences+%28SGMO%29+to+Underweight/7552421.html\">downgraded to Underweight</a> from Neutral on valuation at Piper Jaffray, saying the drug developer has limited clinical data coming through its pipeline this year. <div class=\"tiny-share-widget\" data-id=\"396391\" data-linked=\"Sangamo BioSciences (SGMO -3.1%) takes a hit after being downgraded to Underweight from Neutral...\" data-tweet=\"$SGMO - Sangamo BioSciences (SGMO -3.1%) takes a hit after being downgraded to Underweight from Neutral on valuation at Piper Jaffray, saying the drug developer has limited clinical data coming through its pipeline this year. https://seekingalpha.com/news/396391?source=tweet\" data-url=\"https://seekingalpha.com/news/396391\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396381\" data-ts=\"1341244079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Research In Motion (RIMM -1.7%) makes new lows following Friday&#39;s post-FQ1 bloodletting, as an...</a></h4> Research In Motion (RIMM <font color=\"red\">-1.7%</font>) makes new lows following Friday's post-<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/392451\">FQ1</a> bloodletting, as an upgrade to Buy from Hudson Securities fails to help. Activist investor <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=rimm%20jaguar\">Jaguar Financial</a> is <a target=\"_blank\" href=\"http://www.ibtimes.com/articles/357923/20120629/rim-blackberry-microsoft-heins-research-motion-fir.htm\">stepping up</a> its calls for a sale, and is also demanding the removal of CEO Thorsten Heins and half of RIM's board. Expect some fireworks at RIM's July 10 shareholder meeting. <div class=\"tiny-share-widget\" data-id=\"396381\" data-linked=\"Research In Motion (RIMM -1.7%) makes new lows following Friday&#39;s post-FQ1 bloodletting, as an...\" data-tweet=\"$BB - Research In Motion (RIMM -1.7%) makes new lows following Friday&#39;s post-FQ1 bloodletting, as an upgrade to Buy from Hudson Securities fails to help. Activist investor Jaguar Financial is stepping up its calls for a sale, and is also demanding the r... https://seekingalpha.com/news/396381?source=tweet\" data-url=\"https://seekingalpha.com/news/396381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396321\" data-ts=\"1341243470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Eagle Outfitters (AEO +1.3%) trades higher despite disclosing late last week that it...</a></h4>American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color=\"green\">+1.3%</font>) trades higher despite disclosing late last week that it would take a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394651\">steep loss</a> on winding down its 77kids franchise. Investors are taking a look at the <a target=\"_blank\" href=\"https://seekingalpha.com/article/695401-american-eagle-outfitters-a-no-debt-retailer-with-a-dividend?source=kizur\">big picture</a> on AEO, as a high-growth retail name that carries no debt and pays a 2.23% yield.<div class=\"tiny-share-widget\" data-id=\"396321\" data-linked=\"American Eagle Outfitters (AEO +1.3%) trades higher despite disclosing late last week that it...\" data-tweet=\"$AEO - American Eagle Outfitters (AEO +1.3%) trades higher despite disclosing late last week that it would take a steep loss on winding down its 77kids franchise. Investors are taking a look at the big picture on AEO, as a high-growth retail name that c... https://seekingalpha.com/news/396321?source=tweet\" data-url=\"https://seekingalpha.com/news/396321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396301\" data-ts=\"1341243295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALKS\" target=\"_blank\">ALKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen says Alkermes (ALKS +2.4%) should be bought at current levels , citing the value of its...</a></h4><p>Cowen says Alkermes (<a href=\"https://seekingalpha.com/symbol/ALKS\" title=\"Alkermes plc\">ALKS</a> <font color=\"green\">+2.4%</font>) should be <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=alks&amp;days_back=30&amp;table=none\">bought at current levels</a> , citing the value of its diabetes drug Bydureon and its potential profitability for the company. The firm believes the royalty stream could be worth more than $1B, or $8 per share, which would drive significantly higher valuations. </p><div class=\"tiny-share-widget\" data-id=\"396301\" data-linked=\"Cowen says Alkermes (ALKS +2.4%) should be bought at current levels , citing the value of its...\" data-tweet=\"$ALKS - Cowen says Alkermes (ALKS +2.4%) should be bought at current levels , citing the value of its diabetes drug Bydureon and its potential profitability for the company. The firm believes the royalty stream could be worth more than $1B, or $8 per sh... https://seekingalpha.com/news/396301?source=tweet\" data-url=\"https://seekingalpha.com/news/396301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396281\" data-ts=\"1341242792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin (AMRN +3.7%) is very close to receiving a long-sought patent on its lead drug candidate,...</a></h4><p>Amarin (<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a> <font color=\"green\">+3.7%</font>) is very close to receiving a long-sought patent on its lead drug candidate, AMR101, after the USPTO issues a <a target=\"_blank\" href=\"http://online.wsj.com/article/BT-CO-20120702-704014.html\">Notice of Allowance</a> supporting the use of the fish-oil heart pill in patients with high triglycerides. A Notice of Allowance is typically issued after regulators decide that a patent can be granted from an application. Next up is an FDA decision on AMR101, expected this month. (PR) </p><div class=\"tiny-share-widget\" data-id=\"396281\" data-linked=\"Amarin (AMRN +3.7%) is very close to receiving a long-sought patent on its lead drug candidate,...\" data-tweet=\"$AMRN - Amarin (AMRN +3.7%) is very close to receiving a long-sought patent on its lead drug candidate, AMR101, after the USPTO issues a Notice of Allowance supporting the use of the fish-oil heart pill in patients with high triglycerides. A Notice of A... https://seekingalpha.com/news/396281?source=tweet\" data-url=\"https://seekingalpha.com/news/396281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396271\" data-ts=\"1341242553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron (MU +4.6%) jumps after its purchase of bankrupt rival Elpida becomes official. RBC and...</a></h4> Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color=\"green\">+4.6%</font>) jumps after its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/395431\">purchase</a> of bankrupt rival Elpida becomes official. <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/RBC+Capital+Maintains+an+Outperform+on+Micron+Technology+%28MU%29%3B+Terms+of+Elpida+Deal+Attractive/7553435.html\">RBC</a> and <a target=\"_blank\" href=\"http://www.streetinsider.com/Mergers+and+Acquisitions/Wells+Fargo+Reiterates+an+Outperform+on+Micron+Technology+%28MU%29%3B+Favorable+Terms+for+Elpida+Acquisition/7553467.html\">Wells Fargo</a> join <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/392611\">Nomura</a> in arguing the deal's terms are favorable to Micron - RBC sees Elpida and its <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-07-02/micron-agrees-to-buy-rexchip-stake-amid-elpida-takeover-plans.html\">Rexchip</a> JV increasing both Micron's scale and R&amp;D muscle, and considers the deal's expected ROI and cash flow impact to be encouraging. Still, it cautions assessing Elpida's near-term financial performance could be challenging. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=micron%20%20elpida\">more</a>) <div class=\"tiny-share-widget\" data-id=\"396271\" data-linked=\"Micron (MU +4.6%) jumps after its purchase of bankrupt rival Elpida becomes official. RBC and...\" data-tweet=\"$MU - Micron (MU +4.6%) jumps after its purchase of bankrupt rival Elpida becomes official. RBC and Wells Fargo join Nomura in arguing the deal&#39;s terms are favorable to Micron - RBC sees Elpida and its Rexchip JV increasing both Micron&#39;s scale and R&amp;D m... https://seekingalpha.com/news/396271?source=tweet\" data-url=\"https://seekingalpha.com/news/396271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396241\" data-ts=\"1341242395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Wal-Mart (WMT +0.4%) trade just a hair below $70 as they continues to shrug off the...</a></h4><p>Shares of Wal-Mart (<a href=\"https://seekingalpha.com/symbol/WMT\" title=\"Walmart Inc.\">WMT</a> <font color=\"green\">+0.4%</font>) trade just a hair below $70 as they continues to shrug off the company's scandal in Mexico and etch out new 52-week highs right and left. The prevailing sentiment is that a sluggish, but growing, economy could be sitting in the company's <a target=\"_blank\" href=\"http://money.cnn.com/video/markets/2012/07/02/investing-bz-walmart.cnnmoney/\">sweet spot</a> for maximizing sales as bargain shoppers continue to flock to its stores with nary a thought about bribery allegations.  </p><div class=\"tiny-share-widget\" data-id=\"396241\" data-linked=\"Shares of Wal-Mart (WMT +0.4%) trade just a hair below $70 as they continues to shrug off the...\" data-tweet=\"$WMT - Shares of Wal-Mart (WMT +0.4%) trade just a hair below $70 as they continues to shrug off the company&#39;s scandal in Mexico and etch out new 52-week highs right and left. The prevailing sentiment is that a sluggish, but growing, economy could be si... https://seekingalpha.com/news/396241?source=tweet\" data-url=\"https://seekingalpha.com/news/396241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396231\" data-ts=\"1341241823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDO\" target=\"_blank\">FDO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Family Dollar (FDO +2.2%) trades higher as Johnson Rice upgrades shares to Overweight from...</a></h4>Family Dollar (<a href='https://seekingalpha.com/symbol/FDO' title='Family Dollar Stores Inc.'>FDO</a> <font color=\"green\">+2.2%</font>) trades higher as Johnson Rice upgrades shares to Overweight from Underweight. The discounter trade is back on in light of a fresh wave of discouraging economic data, with Dollar General (<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a> <font color=\"green\">+0.7%</font>), Big Lots (<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> <font color=\"green\">+0.9%</font>), Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color=\"green\">+0.9%</font>), and TJX (<a href='https://seekingalpha.com/symbol/TJX' title='TJX Companies Inc.'>TJX</a> <font color=\"green\">+0.4%</font>) all poking out gains. <div class=\"tiny-share-widget\" data-id=\"396231\" data-linked=\"Family Dollar (FDO +2.2%) trades higher as Johnson Rice upgrades shares to Overweight from...\" data-tweet=\"$FDO $FDO $DG - Family Dollar (FDO +2.2%) trades higher as Johnson Rice upgrades shares to Overweight from Underweight. The discounter trade is back on in light of a fresh wave of discouraging economic data, with Dollar General (DG +0.7%), Big Lots (BIG... https://seekingalpha.com/news/396231?source=tweet\" data-url=\"https://seekingalpha.com/news/396231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396221\" data-ts=\"1341241707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTC\" target=\"_blank\">PTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In addition to Qlik, Jefferies, is downgrading Parametric Technology (PMTC -4.6%) to Hold,...</a></h4><p>In addition to <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/396131\">Qlik</a>, Jefferies, is <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Jefferies+Downgrades+Parametric+Technology+%28PMTC%29+to+Hold/7552475.html\">downgrading</a> Parametric Technology (PMTC <font color=\"red\">-4.6%</font>) to Hold, citing checks that point to weakening demand. The firm adds it expects organic growth, which already appears to be under pressure given Parametric's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/273401\">Q2 guidance</a>, to remain depressed for a while longer. Larger <a target=\"_blank\" href=\"http://en.wikipedia.org/wiki/Computer-aided_design\">CAD software</a> rival Autodesk (<a href=\"https://seekingalpha.com/symbol/ADSK\" title=\"Autodesk, Inc.\">ADSK</a> <font color=\"red\">-1.3%</font>) might be ticking lower in sympathy. </p><div class=\"tiny-share-widget\" data-id=\"396221\" data-linked=\"In addition to Qlik, Jefferies, is downgrading Parametric Technology (PMTC -4.6%) to Hold,...\" data-tweet=\"$PTC $PTC $ADSK - In addition to Qlik, Jefferies, is downgrading Parametric Technology (PMTC -4.6%) to Hold, citing checks that point to weakening demand. The firm adds it expects organic growth, which already appears to be under pressure given Parametr... https://seekingalpha.com/news/396221?source=tweet\" data-url=\"https://seekingalpha.com/news/396221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396151\" data-ts=\"1341240867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNCR\" target=\"_blank\">LNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396151\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lincare (NASDAQ:LNCR) surges 21.5% to $41.33, pretty close to the $41.50/share that Germany&#39;s...</a></h4><p>Lincare (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LNCR\" title=\"Lincare Holdings Inc.\">LNCR</a>) <font color=\"green\">surges 21.5%</font> to $41.33, pretty close to the $41.50/share that Germany's Linde (<a href=\"https://seekingalpha.com/symbol/LNAGF\" title=\"Linde AG\">OTCPK:LNAGF</a>) is <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/395151\">offering to buy</a> the company. The deal somewhat closes a circle, as Lincare was <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424052702304211804577502444200248320.html\">originally an offshoot</a> of Linde at the start of the 20th century. Linde rival Air Liquide (<a href=\"https://seekingalpha.com/symbol/AIQUY\" title=\"L'Air Liquide SA ADR\">OTCPK:AIQUY</a> <font color=\"green\">+0.7%</font>) is little moved by the news. </p><div class=\"tiny-share-widget\" data-id=\"396151\" data-linked=\"Lincare (NASDAQ:LNCR) surges 21.5% to $41.33, pretty close to the $41.50/share that Germany&#39;s...\" data-tweet=\"$LNCR $LNCR $LNAGF - Lincare (NASDAQ:LNCR) surges 21.5% to $41.33, pretty close to the $41.50/share that Germany&#39;s Linde (OTCPK:LNAGF) is offering to buy the company. The deal somewhat closes a circle, as Lincare was originally an offshoot of Linde at t... https://seekingalpha.com/news/396151?source=tweet\" data-url=\"https://seekingalpha.com/news/396151\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396141\" data-ts=\"1341240746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRA\" target=\"_blank\">VRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396141\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Vera Bradley (VRA -8.2%) trail off as the company&#39;s prospects to grow sales globally,...</a></h4><p>Shares of Vera Bradley (<a href=\"https://seekingalpha.com/symbol/VRA\" title=\"Vera Bradley\">VRA</a> <font color=\"red\">-8.2%</font>) trail off as the company's prospects to grow sales globally, particularly China, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394961\">look bleaker</a>. The stock is also a <a target=\"_blank\" href=\"http://www.nasdaq.com/symbol/vra/short-interest\">favored target</a> of shorts and hasn't been able to pull off a squeeze to ease the downside pressure.\n</p><div class=\"tiny-share-widget\" data-id=\"396141\" data-linked=\"Shares of Vera Bradley (VRA -8.2%) trail off as the company&#39;s prospects to grow sales globally,...\" data-tweet=\"$VRA - Shares of Vera Bradley (VRA -8.2%) trail off as the company&#39;s prospects to grow sales globally, particularly China, look bleaker. The stock is also a favored target of shorts and hasn&#39;t been able to pull off a squeeze to ease the downside pressure. https://seekingalpha.com/news/396141?source=tweet\" data-url=\"https://seekingalpha.com/news/396141\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396131\" data-ts=\"1341240535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QLIK\" target=\"_blank\">QLIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qlik Technologies (QLIK -3.5%) falls on a downgrade to Hold from Jefferies, which says checks...</a></h4><p>Qlik Technologies (<a href=\"https://seekingalpha.com/symbol/QLIK\" title=\"Qlik Technologies Inc.\">QLIK</a> <font color=\"red\">-3.5%</font>) falls on a <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Jefferies+Downgrades+Qlik+Technologies+%28QLIK%29+to+Hold/7552480.html\">downgrade to Hol</a>d from Jefferies, which says checks indicate a soft Q2, lower growth for calendar 2012, and \"increasing competitive pressures\" - Qlik competes with IBM, SAP, Oracle, Microstrategy, and many others in the <a target=\"_blank\" href=\"http://en.wikipedia.org/wiki/Business_intelligence\">business intelligence</a> software market. Though Qlik has <a target=\"_blank\" href=\"http://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1340827200000&amp;chddm=27532&amp;chls=IntervalBasedLine&amp;q=NASDAQ:QLIK&amp;ntsp=0\">underperformed</a> as of late, Jefferies thinks there's still a growth premium built into its valuation (over 35x estimated 2013 EPS). </p><div class=\"tiny-share-widget\" data-id=\"396131\" data-linked=\"Qlik Technologies (QLIK -3.5%) falls on a downgrade to Hold from Jefferies, which says checks...\" data-tweet=\"$QLIK - Qlik Technologies (QLIK -3.5%) falls on a downgrade to Hold from Jefferies, which says checks indicate a soft Q2, lower growth for calendar 2012, and &quot;increasing competitive pressures&quot; - Qlik competes with IBM, SAP, Oracle, Microstrategy, and ma... https://seekingalpha.com/news/396131?source=tweet\" data-url=\"https://seekingalpha.com/news/396131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396111\" data-ts=\"1341240058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSFVF\" target=\"_blank\">GSFVF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gasfrac (OTC:GSFVF) +7.9% and adding to a jump of 14.3% on Friday. There doesn&#39;t seem to be any...</a></h4><p>Gasfrac (<a href=\"https://seekingalpha.com/symbol/GSFVF\" title=\"Gasfrac Energy Services, Inc.\">OTC:GSFVF</a>) <font color=\"green\">+7.9%</font> and adding to a jump of 14.3% on Friday. There doesn't seem to be any discernible trigger for the movement unless investors feel the stock had touched a bottom after <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/384471\">falling sharply</a> prior to Friday. </p><div class=\"tiny-share-widget\" data-id=\"396111\" data-linked=\"Gasfrac (OTC:GSFVF) +7.9% and adding to a jump of 14.3% on Friday. There doesn&#39;t seem to be any...\" data-tweet=\"$GSFVF - Gasfrac (OTC:GSFVF) +7.9% and adding to a jump of 14.3% on Friday. There doesn&#39;t seem to be any discernible trigger for the movement unless investors feel the stock had touched a bottom after falling sharply prior to Friday. https://seekingalpha.com/news/396111?source=tweet\" data-url=\"https://seekingalpha.com/news/396111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396101\" data-ts=\"1341239870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil prices resume losses after a brief spike on headlines that Iranian lawmakers are...</a></h4><p>Crude oil prices resume losses after a brief spike on headlines that Iranian lawmakers are drafting a bill to propose <a target=\"_blank\" href=\"http://www.platts.com/RSSFeedDetailedNews/RSSFeed/Shipping/8459181\">blocking the Strait of Hormuz</a> for oil tankers. WTI <font color=\"red\">-2.1%</font> to $83.16. Worth noting: There was <a target=\"_blank\" href=\"http://ftalphaville.ft.com/blog/2012/07/02/1067371/about-fridays-wti-price-surge/\">no spike in volume</a> to match <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394281\">Friday's price surge</a> - blow-out moves typically are associated with a volume spike - and there was no shift in the time structure. </p><div class=\"tiny-share-widget\" data-id=\"396101\" data-linked=\"Crude oil prices resume losses after a brief spike on headlines that Iranian lawmakers are...\" data-tweet=\"$OIL $OIH $USO - Crude oil prices resume losses after a brief spike on headlines that Iranian lawmakers are drafting a bill to propose blocking the Strait of Hormuz for oil tankers. WTI -2.1% to $83.16. Worth noting: There was no spike in volume to matc... https://seekingalpha.com/news/396101?source=tweet\" data-url=\"https://seekingalpha.com/news/396101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396091\" data-ts=\"1341239613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Best Buy (NYSE:BBY) run up a 8.9% gain to hit their highest level in close to two...</a></h4><p>Shares of Best Buy (NYSE:<a href=\"https://seekingalpha.com/symbol/BBY\" title=\"Best Buy Co.\">BBY</a>) run up a <font color=\"green\">8.9% gain</font> to hit their highest level in close to two months. The <a target=\"_blank\" href=\"https://twitter.com/SheilaD_TV/status/219792643113238530\">latest chatter</a> is that Richard Schulze is prepping to take his buyout offer to the board.</p><div class=\"tiny-share-widget\" data-id=\"396091\" data-linked=\"Shares of Best Buy (NYSE:BBY) run up a 8.9% gain to hit their highest level in close to two...\" data-tweet=\"$BBY - Shares of Best Buy (NYSE:BBY) run up a 8.9% gain to hit their highest level in close to two months. The latest chatter is that Richard Schulze is prepping to take his buyout offer to the board. https://seekingalpha.com/news/396091?source=tweet\" data-url=\"https://seekingalpha.com/news/396091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396081\" data-ts=\"1341239611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPEN\" target=\"_blank\">OPEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OpenTable (OPEN -8.9%) falls hard thanks to a downgrade to Equalweight from Barclays, which is...</a></h4> OpenTable (<a href='https://seekingalpha.com/symbol/OPEN' title='OpenTable, Inc.'>OPEN</a> <font color=\"red\">-8.9%</font>) falls hard thanks to a <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Barclays+Downgrades+OpenTable+%28OPEN%29+to+Equalweight/7552515.html\">downgrade to Equalweight</a> from Barclays, which is setting a PT of $43. Shares had <a target=\"_blank\" href=\"http://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1340827200000&amp;chddm=16240&amp;chls=IntervalBasedLine&amp;q=NASDAQ:OPEN&amp;ntsp=0\">rallied over 20%</a> since early May, after getting <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/289781\">crushed</a> by a weak Q1 report. <div class=\"tiny-share-widget\" data-id=\"396081\" data-linked=\"OpenTable (OPEN -8.9%) falls hard thanks to a downgrade to Equalweight from Barclays, which is...\" data-tweet=\"$OPEN - OpenTable (OPEN -8.9%) falls hard thanks to a downgrade to Equalweight from Barclays, which is setting a PT of $43. Shares had rallied over 20% since early May, after getting crushed by a weak Q1 report. https://seekingalpha.com/news/396081?source=tweet\" data-url=\"https://seekingalpha.com/news/396081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396061\" data-ts=\"1341239304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon (GRPN -6.8%) dives below $10 once again after Susquehannna (Neutral) lowers its PT to...</a></h4><p>Groupon (<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a> <font color=\"red\">-6.8%</font>) dives below $10 once again after <a target=\"_blank\" href=\"http://finance.yahoo.com/news/groupon-price-target-lowered-12-124600211.html\">Susquehannna</a> (Neutral) lowers its PT to $12 from $15, citing worries about higher marketing expenses (<em>ed:</em> their <a target=\"_blank\" href=\"https://seekingalpha.com/currents/on-the-move\">decline</a> in Q1 helped fuel Groupon's post-earnings rally) and Groupon's \"take rate\" (its daily deals revenue split with merchants). </p><div class=\"tiny-share-widget\" data-id=\"396061\" data-linked=\"Groupon (GRPN -6.8%) dives below $10 once again after Susquehannna (Neutral) lowers its PT to...\" data-tweet=\"$GRPN - Groupon (GRPN -6.8%) dives below $10 once again after Susquehannna (Neutral) lowers its PT to $12 from $15, citing worries about higher marketing expenses (ed: their decline in Q1 helped fuel Groupon&#39;s post-earnings rally) and Groupon&#39;s &quot;take ra... https://seekingalpha.com/news/396061?source=tweet\" data-url=\"https://seekingalpha.com/news/396061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396021\" data-ts=\"1341238632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADI\" target=\"_blank\">ADI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analog Devices (ADI -1.5%) slumps following a downgrade to Neutral from Sterne Agee. The firm is...</a></h4><p>Analog Devices (<a href=\"https://seekingalpha.com/symbol/ADI\" title=\"Analog Devices Inc.\">ADI</a> <font color=\"red\">-1.5%</font>) slumps following a <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/12/07/2712481/update-sterne-agee-downgrades-analog-devices-to-neutral-\">downgrade to Neutral</a> from Sterne Agee. The firm is worried about the impact of moderating growth in the industrial and auto sectors, as implied by recent <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/395971\">ISM data</a>, and thinks it translates into in-line 2H results. Meanwhile, rival analog chipmaker ON Semiconductor (ONNN <font color=\"red\">-1.4%</font>) is trading lower thanks to a Neutral <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/12/07/2713265/update-sterne-agee-initiates-on-semiconductor-corporatio\">coverage launch</a> from Sterne, which cites macro worries a lack of leverage to any key product cycle. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394691\">O2Micro warning</a>) </p><div class=\"tiny-share-widget\" data-id=\"396021\" data-linked=\"Analog Devices (ADI -1.5%) slumps following a downgrade to Neutral from Sterne Agee. The firm is...\" data-tweet=\"$ADI $ADI $ON - Analog Devices (ADI -1.5%) slumps following a downgrade to Neutral from Sterne Agee. The firm is worried about the impact of moderating growth in the industrial and auto sectors, as implied by recent ISM data, and thinks it translates in... https://seekingalpha.com/news/396021?source=tweet\" data-url=\"https://seekingalpha.com/news/396021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"396011\" data-ts=\"1341238467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWDP\" target=\"_blank\">DWDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/396011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DuPont (DD -3%) tumbles at the open after Jefferies cuts its stock rating to Hold from Buy and...</a></h4><p>DuPont (DD <font color=\"red\">-3%</font>) tumbles at the open after Jefferies <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Jefferies+Downgrades+DuPont+%28DD%29+to+Hold/7552473.html\">cuts its stock rating</a> to Hold from Buy and lowers its price target to $55 from $62. The firm cites deteriorating demand from Europe and weakness in the market for titanium dioxide, a widely used white pigment. \"Multiple expansion appears less likely as capital will likely flow to other recovery plays,\" the firm says. </p><div class=\"tiny-share-widget\" data-id=\"396011\" data-linked=\"DuPont (DD -3%) tumbles at the open after Jefferies cuts its stock rating to Hold from Buy and...\" data-tweet=\"$DWDP $DD - DuPont (DD -3%) tumbles at the open after Jefferies cuts its stock rating to Hold from Buy and lowers its price target to $55 from $62. The firm cites deteriorating demand from Europe and weakness in the market for titanium dioxide, a widely... https://seekingalpha.com/news/396011?source=tweet\" data-url=\"https://seekingalpha.com/news/396011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395951\" data-ts=\"1341237510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YOKU\" target=\"_blank\">YOKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Youku.com (YOKU -4.3%) and merger partner Tudou (TUDO -3.9%) sell off after Youku announces CFO...</a></h4><p>Youku.com (<a href=\"https://seekingalpha.com/symbol/YOKU\" title=\"Youku Tudou Inc.\">YOKU</a> <font color=\"red\">-4.3%</font>) and merger partner Tudou (<a href=\"https://seekingalpha.com/symbol/TUDO\" title=\"Tudou Holdings\">TUDO</a> <font color=\"red\">-3.9%</font>) sell off after Youku announces CFO Dele Liu has been kicked upstairs to President, and that his old job will go to finance SVP Michael Xu. Victor Koo remains chairman and CEO. The many accounting scandals that have hit Chinese ADRs has made the Street jittery about any unexpected CFO transition. (PR) </p><div class=\"tiny-share-widget\" data-id=\"395951\" data-linked=\"Youku.com (YOKU -4.3%) and merger partner Tudou (TUDO -3.9%) sell off after Youku announces CFO...\" data-tweet=\"$YOKU $YOKU $TUDO - Youku.com (YOKU -4.3%) and merger partner Tudou (TUDO -3.9%) sell off after Youku announces CFO Dele Liu has been kicked upstairs to President, and that his old job will go to finance SVP Michael Xu. Victor Koo remains chairman and C... https://seekingalpha.com/news/395951?source=tweet\" data-url=\"https://seekingalpha.com/news/395951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395911\" data-ts=\"1341237077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNLF\" target=\"_blank\">SSNLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Samsung Electronics (OTC:SSNLF) shares fell 2.3% on the Seoul exchange after the Galaxy Nexus...</a></h4><p>Samsung Electronics (<a href=\"https://seekingalpha.com/symbol/SSNLF\" title=\"Samsung Electronics Co., Ltd.\">OTC:SSNLF</a>) shares <font color=\"red\">fell 2.3%</font> on the Seoul exchange after the Galaxy Nexus was <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394791\">hit with a U.S. ban</a> ahead of an upcoming trial with Apple (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a>). Fears are up that the flagship <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=galaxy%20s%20iii\">Galaxy S III</a> could receive similar treatment, given it appears to run afoul of the same <a target=\"_blank\" href=\"http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=8,086,604.PN.&amp;OS=PN/8,086,604&amp;RS=PN/8,086,604\">Apple patent</a> covering the \"innovation\" of being able to search via voice or text through the same interface. Samsung, unsurprisingly, is <a target=\"_blank\" href=\"http://online.wsj.com/article/BT-CO-20120702-702276.html\">appealing</a> the Nexus ruling. </p><div class=\"tiny-share-widget\" data-id=\"395911\" data-linked=\"Samsung Electronics (OTC:SSNLF) shares fell 2.3% on the Seoul exchange after the Galaxy Nexus...\" data-tweet=\"$SSNLF $SSNLF $AAPL - Samsung Electronics (OTC:SSNLF) shares fell 2.3% on the Seoul exchange after the Galaxy Nexus was hit with a U.S. ban ahead of an upcoming trial with Apple (NASDAQ:AAPL). Fears are up that the flagship Galaxy S III could receive si... https://seekingalpha.com/news/395911?source=tweet\" data-url=\"https://seekingalpha.com/news/395911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395891\" data-ts=\"1341236553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMPE\" target=\"_blank\">AMPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ampio&#39;s (NYSEMKT:AMPE) surge today follows a 29% jump on Friday, which Reuters said followed a...</a></h4> Ampio's (NYSEMKT:<a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/395821\">surge today</a> follows a 29% jump on Friday, which <a target=\"_blank\" href=\"http://www.chicagotribune.com/health/sns-rt-us-ampiopharma-sharesbre85s13d-20120629,0,6569717.story\">Reuters said</a> followed a <a target=\"_blank\" href=\"https://seekingalpha.com/article/691831-traders-eye-ampio\">positive article</a> from SA contributor Richard Cavalli. Cavalli wrote that \"with 3 blockbuster drugs and a revolutionary diagnostic,\" the company \"is likely to be another stellar rocket.\" <div class=\"tiny-share-widget\" data-id=\"395891\" data-linked=\"Ampio&#39;s (NYSEMKT:AMPE) surge today follows a 29% jump on Friday, which Reuters said followed a...\" data-tweet=\"$AMPE - Ampio&#39;s (NYSEMKT:AMPE) surge today follows a 29% jump on Friday, which Reuters said followed a positive article from SA contributor Richard Cavalli. Cavalli wrote that &quot;with 3 blockbuster drugs and a revolutionary diagnostic,&quot; the company &quot;is li... https://seekingalpha.com/news/395891?source=tweet\" data-url=\"https://seekingalpha.com/news/395891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395871\" data-ts=\"1341236318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNX\" target=\"_blank\">CNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consol Energy (CNX +2%) sells non-producing assets in Wyoming&#39;s Northern Powder River Basin coal...</a></h4><p>Consol Energy (<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"green\">+2%</font>) sells non-producing assets  in Wyoming's Northern Powder River Basin coal fields to Cloud Peak Energy (<a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"green\">+1.5%</font>) for $170M in cash to fund its capital spending for the year. CNX says it structured the transaction  to retain an 8% production royalty interest on ~200M tons  of permitted fee coal. </p><div class=\"tiny-share-widget\" data-id=\"395871\" data-linked=\"Consol Energy (CNX +2%) sells non-producing assets in Wyoming&#39;s Northern Powder River Basin coal...\" data-tweet=\"$CNX $CNX $CLDPQ - Consol Energy (CNX +2%) sells non-producing assets in Wyoming&#39;s Northern Powder River Basin coal fields to Cloud Peak Energy (CLD +1.5%) for $170M in cash to fund its capital spending for the year. CNX says it structured the transacti... https://seekingalpha.com/news/395871?source=tweet\" data-url=\"https://seekingalpha.com/news/395871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395831\" data-ts=\"1341235795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cirrus Logic (NASDAQ:CRUS) -1.9% after Oppenheimer downgrades shares to Perform on account of...</a></h4><p>Cirrus Logic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CRUS\" title=\"Cirrus Logic, Inc.\">CRUS</a>) <font color=\"red\">-1.9%</font> after Oppenheimer <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/12/07/2713141/update-oppenheimer-downgrades-cirrus-logic-to-perform-on\">downgrades</a> shares to Perform on account of the company's 88% 2012 run-up. While calling Cirrus \"one of the best pure-plays\" on Apple's success, the firm thinks its valuation makes upside \"difficult to achieve,\" and suggests Cirrus' heavy dependence on Apple (expected to be an 80%+ customer by year's end) represents a risk. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/377191\">Needham downgrade</a>) </p><div class=\"tiny-share-widget\" data-id=\"395831\" data-linked=\"Cirrus Logic (NASDAQ:CRUS) -1.9% after Oppenheimer downgrades shares to Perform on account of...\" data-tweet=\"$CRUS - Cirrus Logic (NASDAQ:CRUS) -1.9% after Oppenheimer downgrades shares to Perform on account of the company&#39;s 88% 2012 run-up. While calling Cirrus &quot;one of the best pure-plays&quot; on Apple&#39;s success, the firm thinks its valuation makes upside &quot;diffic... https://seekingalpha.com/news/395831?source=tweet\" data-url=\"https://seekingalpha.com/news/395831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395821\" data-ts=\"1341235780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMPE\" target=\"_blank\">AMPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ampio Pharmaceuticals (NYSEMKT:AMPE) +18.1% premarket after announcing an agreement with...</a></h4><p>Ampio Pharmaceuticals (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/AMPE\" title=\"Ampio Pharmaceuticals, Inc.\">AMPE</a>) <font color=\"green\">+18.1%</font> premarket after announcing an agreement with India-based Syngene to manufacture a combination product, Zertane-ED, to treat certain male sexual dysfunctions. The product will be used in Phase 3 trials in South Korea with AMPE partner Daewoong, which will finance and conduct the trials. </p><div class=\"tiny-share-widget\" data-id=\"395821\" data-linked=\"Ampio Pharmaceuticals (NYSEMKT:AMPE) +18.1% premarket after announcing an agreement with...\" data-tweet=\"$AMPE - Ampio Pharmaceuticals (NYSEMKT:AMPE) +18.1% premarket after announcing an agreement with India-based Syngene to manufacture a combination product, Zertane-ED, to treat certain male sexual dysfunctions. The product will be used in Phase 3 trials ... https://seekingalpha.com/news/395821?source=tweet\" data-url=\"https://seekingalpha.com/news/395821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395811\" data-ts=\"1341235430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CECO\" target=\"_blank\">CECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395811\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Education stocks keep up their bouncy trading with the impact on the compromises embedded in the...</a></h4><p>Education stocks keep up their bouncy trading with the <a target=\"_blank\" href=\"http://www.cnn.com/2012/06/29/politics/congress-highway-bill/index.html\">impact</a> on the compromises embedded in the student loan provision in the transportation funding bill still getting bandied about. Though the headliner item that student loan rates will be held steady at 3.4% is tipping sentiment for the moment, analysts <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/389381\">warn</a> that federal funding for student loans will become trickier over time. Premarket: <a href=\"https://seekingalpha.com/symbol/CECO\" title=\"Career Education Corporation\">CECO</a> <font color=\"green\">+5.4%</font>, <a href=\"https://seekingalpha.com/symbol/COCO\" title=\"Corinthian Colleges, Inc.\">COCO</a> <font color=\"green\">+8.0%</font>, <a href=\"https://seekingalpha.com/symbol/APOL\" title=\"Apollo Education Group, Inc.\">APOL</a> <font color=\"green\">+2.8%</font>, DV <font color=\"green\">+1.3%</font>.</p><div class=\"tiny-share-widget\" data-id=\"395811\" data-linked=\"Education stocks keep up their bouncy trading with the impact on the compromises embedded in the...\" data-tweet=\"$CECO $CECO $COCO - Education stocks keep up their bouncy trading with the impact on the compromises embedded in the student loan provision in the transportation funding bill still getting bandied about. Though the headliner item that student loan rates... https://seekingalpha.com/news/395811?source=tweet\" data-url=\"https://seekingalpha.com/news/395811\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395801\" data-ts=\"1341234950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: Stock futures remain flat after PMI Manufacturing falls to its weakest since...</a></h4><b>Market preview:</b> Stock futures remain flat after PMI Manufacturing <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/395741\">falls</a> to its weakest since December 2010, with the S&amp;B benchmark slightly in the green. EU shares are mainly higher despite Finland and Holland threatening to put a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/395461\">spoke in the wheel</a> of eurobonds. In corporate news, Amylin <font color=\"green\">+8.9%</font> on news it's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394871\">being bought</a> by Bristol-Myers and AstraZeneca. <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/395101\">Later</a>: ISM Manufacturing Index, Construction Spending Fed's Williams <div class=\"tiny-share-widget\" data-id=\"395801\" data-linked=\"Market preview: Stock futures remain flat after PMI Manufacturing falls to its weakest since...\" data-tweet=\"Market preview: Stock futures remain flat after PMI Manufacturing falls to its weakest since December 2010, with the S&amp;B benchmark slightly in the green. EU shares are mainly higher despite Finland and Holland threatening to put a spoke in the wheel of ... https://seekingalpha.com/news/395801?source=tweet\" data-url=\"https://seekingalpha.com/news/395801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395791\" data-ts=\"1341234939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAAS\" target=\"_blank\">PAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pan American Silver (NASDAQ:PAAS) says new regulations proposed in Argentina&#39;s Chubut province,...</a></h4><p>Pan American Silver (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PAAS\" title=\"Pan American Silver Corp.\">PAAS</a>) says new regulations proposed in Argentina's Chubut province, where its Navidad mining project is located, would greatly increase royalties and impose economic participation by the province in all mining projects. \"Without clear potential for positive economic returns, further investment and project expenditures cannot be justified.\" PAAS <font color=\"red\">-3.1%</font> premarket. </p><div class=\"tiny-share-widget\" data-id=\"395791\" data-linked=\"Pan American Silver (NASDAQ:PAAS) says new regulations proposed in Argentina&#39;s Chubut province,...\" data-tweet=\"$PAAS - Pan American Silver (NASDAQ:PAAS) says new regulations proposed in Argentina&#39;s Chubut province, where its Navidad mining project is located, would greatly increase royalties and impose economic participation by the province in all mining project... https://seekingalpha.com/news/395791?source=tweet\" data-url=\"https://seekingalpha.com/news/395791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395761\" data-ts=\"1341234626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELL\" target=\"_blank\">CELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: CELL +64%. LNCR +21%. AMPE +17%. ATPG +13%. WFR +9%. AMLN +9%. MU +7%....</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/CELL\" title=\"Brightpoint, Inc.\">CELL</a> <font color=\"green\">+64%</font>. <a href=\"https://seekingalpha.com/symbol/LNCR\" title=\"Lincare Holdings Inc.\">LNCR</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/AMPE\" title=\"Ampio Pharmaceuticals, Inc.\">AMPE</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/ATPG\" title=\"\">ATPG</a> <font color=\"green\">+13%</font>. WFR <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/AMLN\" title=\"\">AMLN</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+7%</font>.<br> <b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ANH\" title=\"Anworth Mortgage Asset Corporation\">ANH</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/OREX\" title=\"Orexigen Therapeutics, Inc.\">OREX</a> <font color=\"red\">-5%</font>. <a href=\"https://seekingalpha.com/symbol/CORT\" title=\"Corcept Therapeutics Incorporated\">CORT</a> <font color=\"red\">-5%</font>. <div class=\"tiny-share-widget\" data-id=\"395761\" data-linked=\"Premarket gainers: CELL +64%. LNCR +21%. AMPE +17%. ATPG +13%. WFR +9%. AMLN +9%. MU +7%....\" data-tweet=\"$CELL $CELL $LNCR - Premarket gainers: CELL +64%. LNCR +21%. AMPE +17%. ATPG +13%. WFR +9%. AMLN +9%. MU +7%. Losers: ANH -6%. OREX -5%. CORT -5%. https://seekingalpha.com/news/395761?source=tweet\" data-url=\"https://seekingalpha.com/news/395761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395731\" data-ts=\"1341234210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields (NYSE:GFI) -1.7% premarket after five miners died from smoke inhalation at a GFI...</a></h4><p>Gold Fields (NYSE:<a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a>) <font color=\"red\">-1.7%</font> premarket after <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/07/01/safrica-mine-deaths-idUSL6E8I10AG20120701\">five miners died</a> from smoke inhalation at a GFI mine in South Africa over the weekend as they worked underground. The deaths are a setback for the government and the industry as they try to improve safety and reduce fatalities in South Africa's mines, the world's deepest. </p><div class=\"tiny-share-widget\" data-id=\"395731\" data-linked=\"Gold Fields (NYSE:GFI) -1.7% premarket after five miners died from smoke inhalation at a GFI...\" data-tweet=\"$GFI - Gold Fields (NYSE:GFI) -1.7% premarket after five miners died from smoke inhalation at a GFI mine in South Africa over the weekend as they worked underground. The deaths are a setback for the government and the industry as they try to improve saf... https://seekingalpha.com/news/395731?source=tweet\" data-url=\"https://seekingalpha.com/news/395731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395671\" data-ts=\"1341233334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amylin (AMLN) +9% to $30.75 following news it&#39;s being bought by Bristol-Myers Squibb (BMY -0.1%)...</a></h4> Amylin (<a href='https://seekingalpha.com/symbol/AMLN' title=''>AMLN</a>) <font color=\"green\">+9%</font> to $30.75 <a target=\"_blank\" href=\"http://finance.yahoo.com/news/ahead-bell-amylin-pharma-shares-123019938.html\" target=\"_blank\">following news</a> it's being bought by Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.1%</font>) and AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color=\"red\">-0.1%</font>) in a 31/share <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/394871\" target=\"_blank\">deal worth $7B</a>. Bernstein analyst Tim Anderson says BMY and AZN are the most logical buyers, although he doesn't think the transaction will significantly alter the financial outlook for either company. <div class=\"tiny-share-widget\" data-id=\"395671\" data-linked=\"Amylin (AMLN) +9% to $30.75 following news it&#39;s being bought by Bristol-Myers Squibb (BMY -0.1%)...\" data-tweet=\"$BMY $BMY $AZN - Amylin (AMLN) +9% to $30.75 following news it&#39;s being bought by Bristol-Myers Squibb (BMY -0.1%) and AstraZeneca (AZN -0.1%) in a 31/share deal worth $7B. Bernstein analyst Tim Anderson says BMY and AZN are the most logical buyers, alth... https://seekingalpha.com/news/395671?source=tweet\" data-url=\"https://seekingalpha.com/news/395671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395641\" data-ts=\"1341233066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATPAQ\" target=\"_blank\">ATPAQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ATP Oil &amp;amp; Gas (ATPG) +11.9% premarket after announcing the Shimson well off the coast of...</a></h4><p>ATP Oil &amp; Gas (<a href=\"https://seekingalpha.com/symbol/ATPG\" title=\"\">ATPG</a>) <font color=\"green\">+11.9%</font> premarket after announcing the Shimson well off the coast of  Israel hit more than 62 feet of natural gas pay. The well is in a water depth of 3,622 feet and  was drilled to a subsea depth of 14,445 feet. ATPG, which owns 40% of the find, says it expects to provide additional information about the discovery during Q3. </p><div class=\"tiny-share-widget\" data-id=\"395641\" data-linked=\"ATP Oil &amp;amp; Gas (ATPG) +11.9% premarket after announcing the Shimson well off the coast of...\" data-tweet=\"$ATPAQ - ATP Oil &amp; Gas (ATPG) +11.9% premarket after announcing the Shimson well off the coast of Israel hit more than 62 feet of natural gas pay. The well is in a water depth of 3,622 feet and was drilled to a subsea depth of 14,445 feet. ATPG, which o... https://seekingalpha.com/news/395641?source=tweet\" data-url=\"https://seekingalpha.com/news/395641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395621\" data-ts=\"1341232680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORT\" target=\"_blank\">CORT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corcept Therapeutics (NASDAQ:CORT) intends to sell 11M shares to raise funds for R&amp;amp;D and...</a></h4><p>Corcept Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CORT\" title=\"Corcept Therapeutics Incorporated\">CORT</a>) <a target=\"_blank\" href=\"http://www.marketwatch.com/story/corcept-therapeutics-plans-to-sell-11m-shares-2012-07-02\">intends to sell</a> 11M shares to raise funds for R&amp;D and other purposes. Corcept develops drugs for severe psychiatric and metabolic disorders, including Cushing's syndrome and psychotic depression. Shares <font color=\"red\">-5.35%</font> premarket. (PR) </p><div class=\"tiny-share-widget\" data-id=\"395621\" data-linked=\"Corcept Therapeutics (NASDAQ:CORT) intends to sell 11M shares to raise funds for R&amp;amp;D and...\" data-tweet=\"$CORT - Corcept Therapeutics (NASDAQ:CORT) intends to sell 11M shares to raise funds for R&amp;D and other purposes. Corcept develops drugs for severe psychiatric and metabolic disorders, including Cushing&#39;s syndrome and psychotic depression. Shares -5.35% ... https://seekingalpha.com/news/395621?source=tweet\" data-url=\"https://seekingalpha.com/news/395621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"395531\" data-ts=\"1341231485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/395531\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSK&#39;s (NYSE:GSK) once-daily lung drug LAMA/LABA performed well in late-stage testing in patients...</a></h4><p>GSK's (NYSE:<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>) once-daily lung drug LAMA/LABA <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/07/02/us-glaxosmithkline-lamalaba-idUSBRE8610AT20120702\">performed well</a> in late-stage testing in patients with chronic obstructive pulmonary disease. GSK, which plans to begin filing for regulatory approval at the end of the year, hopes LAMA/LABA will be a successor to Advair. GSK is developing the drug with Theravance (THRX), whose shares are <font color=\"green\">+8%</font>. </p><div class=\"tiny-share-widget\" data-id=\"395531\" data-linked=\"GSK&#39;s (NYSE:GSK) once-daily lung drug LAMA/LABA performed well in late-stage testing in patients...\" data-tweet=\"$GSK $GSK $INVA - GSK&#39;s (NYSE:GSK) once-daily lung drug LAMA/LABA performed well in late-stage testing in patients with chronic obstructive pulmonary disease. GSK, which plans to begin filing for regulatory approval at the end of the year, hopes LAMA/LA... https://seekingalpha.com/news/395531?source=tweet\" data-url=\"https://seekingalpha.com/news/395531\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li>","count":61,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}